News Release | November 17, 2022
Forty-Seven Percent of Persons With Type 2 Diabetes Say a Remote Patient Monitoring (RPM) Program Would Help Them Better Manage Their Health
Smart Meter is the foundation of the RPM Ecosystem
Smart Meter’s unique cellular technology facilitates the delivery of reliable, accurate patient testing data seamlessly to healthcare professionals via our distributors’ platforms.
Smart Meter is the foundation of the RPM Ecosystem
Smart Meter’s unique cellular technology facilitates the delivery of reliable, accurate patient testing data seamlessly to healthcare professionals via our distributors’ platforms.
SmartTouch is Guaranteed to
Increase Patient Engagement
SmartTouch is Smart Meter’s turnkey, branded outreach program that is proven to increase testing adherence in the critical first 30-day window of use and beyond.
Smart Meter by the Numbers
350+
Distribution Partners
150,000+
Patients Monitored Daily
2M+
Monthly Patient Tests
99.9%
Device reliability1
Smart Meter by the Numbers
350+
Distribution Partners
150,000+
Patients Monitored Daily
2M+
Monthly Patient Tests
99.9%
Device reliability1
Our Cellular-Connected Devices
US Patent Nos.: 10,311,208; 10,783,987; 10,783,988. UK Patent No. GB2542056. Canada Patent No. 2953253
Now Available with an Extra-Large Cuff
Our Cellular-Connected Devices
US Patent Nos.: 10,311,208; 10,783,987; 10,783,988. UK Patent No. GB2542056. Canada Patent No. 2953253
Current Partners
Join the hundreds of market-leading RPM companies utilizing Smart Meter’s powerful cellular SmartRPM technology.
Cellular Remote Patient Monitoring:
Immediate. Reliable. Actionable.
Smart Meter eliminates the complex, extra steps—and delay—of sharing health metrics. All patients do is test by pressing a single button on iGlucose, iBloodPressure, iPulseOx or simply stepping on the iScale. Clinicians benefit from access to cellular transmitted, real-time, reliable and secure patient data between visits, which can lead to better patient outcomes.
Testimonials
"iGlucose’s ability to send BG data to our platform without syncing, pairing, home hubs or cables, is the perfect solution."– Joshua Claman, Former Chief Executive Officer, Rimidi
"Data flowing into the population management portal has quickly become an essential tool in managing diabetes for our patients. …iGlucose system drives better outcomes for our patients."– Joel Okner, MD, Cardiologist
"The iGlucose system with real-time data adds tremendous value to our diabetes education program ... The ability to have real-time data in making therapy decisions has been a huge plus."– Vivian N. Ayuk, PharmD, CDE, Chief Executive Officer, Flexcare Health Solutions
"Because of the remote patient monitoring available with your iGlucose meters, we will discuss the utility of remote patient monitoring for many patients. I can’t thank your company enough for enabling our future physicians an opportunity to gain an understanding of what they might ask of their future patients. "– Kathryn R Goldman, MD, Assistant Professor of Medicine, University of Connecticut School of Medicine
News + Events
Forty-Seven Percent of Persons With Type 2 Diabetes Say a Remote Patient Monitoring (RPM) Program Would Help Them Better Manage Their Health
Read More | November 17, 2022
News Release | November 10, 2022
Forty-Six Percent of Adults with Type 2 Diabetes Don’t See Their Physicians as Often as Recommended
Smart Meter partners with AT&T IoT for better health outcomes
Read More | January 3, 2022
*Better Data. Better Care. Better Outcomes. Reference: Self-Monitoring of Blood Glucose: A Prerequisite for Diabetes Management in Outcome Trials Oliver Schnell, MD1, Markolf Hanefeld, MD2, and Louis Monnier, MD3
1 – 99.9% of active patients have zero product issues based on over 2 million clinical readings March – August 2021.